FcRn (FCGRT & B2M)

FcRn (FCGRT & B2M)

FcRn (FCGRT & B2M) Overview

Molecule Name
IgG receptor FcRn large subunit p51
Synonyms
FcRn,FCGRT & B2M
Drug Development Progress
Drugs in Clinical Trials4
Approved Drugs4
Highest Development StageApproved
Target Synonym
Alpha-Chain,FcRn,Major Histocompatibility Complex Class I-Like Fc Receptor,Immunoglobulin Receptor, Intestinal, Heavy Chain,Neonatal Fc-Receptor For Ig,FcRn Alpha Chain,FCGRT,IgG Fc fragment receptor transporter alpha chain,Neonatal Fc receptor,Fc Fragment Of IgG Receptor And Transporter,Transmembrane Alpha Chain Of The Neonatal Receptor,Fc Fragment Of IgG, Receptor, Transporter, Alpha,IgG receptor FcRn large subunit p51,Heavy Chain Of The Major Histocompatibility Complex Class I-Like Fc Receptor
Background
FCGRT & B2M heterodimer protein (FcRn complex) consist of two subunits: p51 (equivalent to FCGRT), and p14 (equivalent to beta-2-microglobulin), and forms an MHC class I-like heterodimer. Fc fragment of IgG, receptor, transporter, alpha (FCGRT) binds to the Fc region of monomeric immunoglobulins gamma and mediates the uptake of IgG from milk. FCGRT possible role in transfer of immunoglobulin G from mother to fetus. Beta-2-microglobulin (B2M) is a component of the class I major histocompatibility complex (MHC) and involved in the presentation of peptide antigens to the immune system.

FcRn (FCGRT & B2M) Product List

Species
  • Human(6)
  • Cynomolgus / Rhesus macaque(4)
  • Mouse(4)
  • Canine(2)
  • Rabbit(2)
  • Rat(2)
  • Feline(1)
  • Porcine(1)
Tag
  • His Tag & Avi Tag(6)
  • His Tag & Strep Tag(6)
  • His Tag(5)
  • His Tag & Avi Tag & Strep Tag(4)
  • Strep Tag(1)
Host
  • HEK293(22)
Conjugate
  • Biotin-labeled(11)
  • Unconjugated(11)
Grade
  • RUO(22)
Low Endotoxin
  • Yes(1)
  • No(21)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
FcRn (FCGRT & B2M)
HOTAvitag
FCM-C82W9
Biotinylated Canine FcRn / FCGRT&B2M Heterodimer Protein, His,Avitag™&Tag Free (MALS & SPR verified)
Canine
HEK293
MALSSDS-PAGE
ELISASPR

$455.00

25ug
FcRn (FCGRT & B2M)
Human FcRn / FCGRT&B2M Heterodimer Protein, His Tag (SPR & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLI

$360.00

50ug
FcRn (FCGRT & B2M)
HOTAvitag
FCM-H82W7
Biotinylated Human FcRn / FCGRT&B2M Heterodimer Protein, His,Avitag™ (MALS & SPR verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLI

$470.00

25ug
FcRn (FCGRT & B2M)
Human FcRn / FCGRT&B2M Heterodimer Protein, Strep Tag&Tag Free (MALS & SPR verified)
Human
HEK293
MALSSDS-PAGE
SPR

$575.00

50ug
FcRn (FCGRT & B2M)
Human FcRn / FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag, low endotoxin (SPR & HPLC verified)
Human
HEK293
HPLCSDS-PAGE
ELISASPRBLI

$360.00

50ug
FcRn (FCGRT & B2M)
Cynomolgus / Rhesus macaque FcRn / FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR & MALS verified)
Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
SPRBLI

$360.00

50ug
FcRn (FCGRT & B2M)
Canine FcRn / FCGRT&B2M Heterodimer Protein, His Tag&Tag Free (MALS & SPR verified)
Canine
HEK293
MALSSDS-PAGE
SPR

$470.00

100ug
FcRn (FCGRT & B2M)
Cynomolgus / Rhesus macaque FcRn / FCGRT&B2M Heterodimer Protein, His Tag (MALS & SPR verified)
Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
SPRBLI

$470.00

50ug
FcRn (FCGRT & B2M)
Avitag
FCM-C82W3
Biotinylated Cynomolgus / Rhesus macaque FcRn / FCGRT&B2M Heterodimer Protein, His,Avitag™ (MALS & SPR verified)
Cynomolgus / Rhesus macaque
HEK293
MALSSDS-PAGE
SPRBLI

$470.00

25ug
FcRn (FCGRT & B2M)
Avitag
FCM-C82W5
Biotinylated Cynomolgus / Rhesus macaque FcRn Heterodimer Protein, His,Avitag™&Strep II Tag (HPLC & SPR verified)
Cynomolgus / Rhesus macaque
HEK293
HPLCSDS-PAGE
SPRBLI

$360.00

25ug
You Have Viewed 1-10 Of 22 Results
  • 1
  • 2
  • 3

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IMVT-1402IMVT-1402; HL-161 ANSPhase 3 ClinicalHanAll Biopharma Co Ltd
Arthritis, Rheumatoid; Autoimmune Diseases; Graves Disease; Lupus Erythematosus, Cutaneous; Myasthenia Gravis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sjogren's Syndrome
Details
STSA-1301STSA-1301; STSA1301Phase 2 ClinicalStaidson(Beijing) Biopharmaceuticals Co Ltd
Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
ARGX-124ARGX124; ARGX-124Phase 1 ClinicalArgenx Se
Immune System Diseases
Details
ARGX-213ARGX-213Phase 1 ClinicalArgenx Se
Autoimmune Diseases
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Efgartigimod alfaEFG PH20 SC; PH20 SC; ARGX-113-2308; ARGX-113; EFG PH20ApprovedArgenx SeVYVDURA, VYVGART HYTRULO, 卫伟迦, VYVGARTUnited StatesMyasthenia GravisArgenx BV2021-12-17
Epidermolysis Bullosa; Epidermolysis Bullosa Acquisita; Epidermolysis Bullosa Dystrophica; Eye Diseases; Glomerulonephritis, Membranous; Graves Ophthalmopathy; Guillain-Barre Syndrome; Immunoglobulin G4-Related Disease; Lupus Nephritis; Muscular Diseases; Myasthenia Gravis; Myositis; Nephrosis; Nephrotic Syndrome; Optic Neuritis; Pemphigoid, Bullous; Pemphigus; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Postural Orthostatic Tachycardia Syndrome; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Rejection of organ transplantation; Scleroderma, Systemic; Sjogren's Syndrome; Stiff-Person Syndrome; Tachycardia; Thrombocytopenia
Details
NipocalimabM-281; JNJ-80202135ApprovedMomenta Pharmaceuticals IncIMAAVYUnited StatesMyasthenia GravisJanssen Biotech Inc2025-04-29
Anemia, Hemolytic, Autoimmune; Arthritis, Rheumatoid; Hemolysis; Lupus Erythematosus, Systemic; Lupus Nephritis; Myasthenia Gravis; Myositis; Pemphigoid, Bullous; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sjogren's Syndrome; Thrombocytopenia, Neonatal Alloimmune
Details
RozanolixizumabUCB-7665ApprovedUcb SaRYSTIGGO, 优迪革United StatesMyasthenia GravisUcb Inc2023-06-27
Encephalitis; Fibromyalgia; Myasthenia Gravis; Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Purpura, Thrombocytopenic, Idiopathic
Details
Efgartigimod alfa/HyaluronidaseApprovedArgenx BVVYVDURA, VYVGART HYTRULOUnited StatesMyasthenia GravisArgenx BV2023-06-20
Anti-synthetase Syndrome; Dermatomyositis; Muscular Diseases; Myasthenia Gravis; Myositis; Polymyositis; Polyradiculoneuropathy; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Details
Customer Reviews